1-2 of 2
Silvia Govi, M.D.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Six-Month Regimen of Oral Clarithromycin Is a Feasible and Active Therapy for Patients with Relapsed/Refractory Marginal Zone B-Cell Lymphoma of MALT-Type

Andres JM Ferreri, MD, Giuseppina Patrizia Dognini, M.D., Roberto Crocchiolo, M.D., Silvia Govi, M.D., Giada Licata, M.D., Maurilio Ponzoni, M.D., Antonio Giordano Resti, M.D., Letterio Salvatore Politi, M.D., Alberto Rosso, M.D., Eugenio Villa, M.D.
Journal: Blood
Blood (2008) 112 (11): 3062.
https://doi.org/10.1182/blood.V112.11.3062.3062
Published: 2008
Journal Articles

A Cumulative Series from 14 Western Countries Suggests That Rituximab Significantly Changed the Dismal Natural History of Intravascular Large B-Cell Lymphoma (IVL) .

Andres JM Ferreri, MD, Silvia Govi, M.D., Giuseppina Patrizia Dognini, M.D., Maria Bouzani, M.D., Claudia Ruth Bollinguer, M.D., Michel D’Incan, M.D., Emmanuel Delaporte, M.D., Mehdi Hamadani, M.D., Fabrice Jardin, M.D., Magdalena Martusewicz-Boros, M.D., Mauro Montanari, M.D., Arpad Szomor, M.D., Roberto Crocchiolo, M.D., Emanuele Zucca, M.D., Franco Cavalli, M.D., Maurilio Ponzoni, M.D.
Journal: Blood
Blood (2008) 112 (11): 2008.
https://doi.org/10.1182/blood.V112.11.2008.2008
Published: 2008